Virax Biolabs Group (VRAX) News Today $1.88 -0.04 (-2.08%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Virax Biolabs announces distribution agreement with Europa BiositeOctober 24, 2024 | markets.businessinsider.comVirax Biolabs Expands Reach with Europa Biosite DealOctober 24, 2024 | markets.businessinsider.comVirax Biolabs Signs Distribution Agreement With Europa Biosite To Sell ImmuneSelect; Stock UpOctober 23, 2024 | markets.businessinsider.comVirax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and IrelandOctober 23, 2024 | prnewswire.comVirax Biolabs Group Ltd Class A VRAXOctober 6, 2024 | morningstar.comVirax Biolabs Group (NASDAQ:VRAX) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comNovo Nordisk A/S (NOVA.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comVirax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.September 16, 2024 | prnewswire.comVirax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment ConferenceSeptember 9, 2024 | prnewswire.comVirax Biolabs to Participate at 7th European Congress of ImmunologyAugust 29, 2024 | prnewswire.comWhy Virax Biolabs Is Rising In Pre-market?August 29, 2024 | markets.businessinsider.comWhat's Going On With Virax Biolabs Stock WednesdayAugust 29, 2024 | msn.comVirax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle EastAugust 28, 2024 | prnewswire.comVirax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary SharesAugust 23, 2024 | prnewswire.comVirax Biolabs Announces Stock Offering: What To KnowAugust 22, 2024 | msn.comVirax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary SharesAugust 21, 2024 | prnewswire.comVirax Biolabs Group (NASDAQ:VRAX) Stock Quotes, Forecast and News SummaryAugust 20, 2024 | benzinga.comVirax Biolabs Shares Climb With Mpox Cases: What To KnowAugust 19, 2024 | msn.comVRAX Virax Biolabs Group LimitedJuly 21, 2024 | seekingalpha.comWhy Is Virax Biolabs (VRAX) Stock Down 15% Today?June 7, 2024 | investorplace.comWhy Is Virax Biolabs (VRAX) Stock Up 115% Today?June 6, 2024 | investorplace.comVirax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024April 25, 2024 | prnewswire.comVirax Biolabs to Participate at ESCMID Global 2024April 16, 2024 | finance.yahoo.comVirax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price DeficiencyMarch 15, 2024 | prnewswire.comVirax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID PatientsDecember 21, 2023 | finance.yahoo.comTrading was temporarily halted for "VRAX" at 07:12 PM with a stated reason of "News pending."December 18, 2023 | marketbeat.comVirax Biolabs announces 1-for-10 share consolidationDecember 14, 2023 | msn.comVirax Biolabs Group Limited Announces 1-for-10 Share ConsolidationDecember 14, 2023 | finance.yahoo.comVirax Biolabs files for up to $30M mixed securities shelfDecember 7, 2023 | msn.comVirax Biolabs Group Ltd OrdOctober 2, 2023 | thestreet.comVRAX: Virax Biolabs transformative preventive diagnostic platform supports higher stock price.September 21, 2023 | finance.yahoo.comVirax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts WebinarSeptember 12, 2023 | finance.yahoo.comVirax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth MomentumSeptember 1, 2023 | finance.yahoo.comNasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 BidAugust 3, 2023 | finance.yahoo.comVRAX: Virax Biolabs releases shareholder letter and financial results for the fiscal year ending March 31, 2023.June 21, 2023 | finance.yahoo.comVRAX: UPDATE: Innovative biotechnology company developing a potentially groundbreaking immunology platform based around proprietary T-Cell testing technology.May 5, 2023 | finance.yahoo.comVirax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science ParkMay 4, 2023 | finance.yahoo.comVirax Biolabs Group Limited Ordinary Shares (VRAX)April 21, 2023 | nasdaq.comVirax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesMarch 10, 2023 | finance.yahoo.comVirax Biolabs Group Stock (NASDAQ:VRAX), DividendsMarch 8, 2023 | benzinga.comVirax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesMarch 8, 2023 | finance.yahoo.comVirax Biolabs Stock Soars On Avian Flu Test Kit Agreement: What's Going On?March 7, 2023 | msn.comEXCLUSIVE: Virax Biolabs Starts Distribution Of Avian Flu Test Kits In EuropeMarch 7, 2023 | finance.yahoo.comWhy Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionMarch 7, 2023 | benzinga.comVirax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test KitMarch 7, 2023 | prnewswire.comVRAX: INITIATION: Innovative biotechnology company developing a potentially groundbreaking immunology platform based around proprietary T-Cell testing technologyFebruary 16, 2023 | finance.yahoo.comNew York City scraps COVID vaccine mandate for public-sector workers. ‘This is the right moment for this decision,’ Mayor Adams says.February 7, 2023 | finance.yahoo.comVirax Biolabs to Present at the 2023 BIO CEO & Investor ConferenceFebruary 6, 2023 | finance.yahoo.comVirax Biolabs' CEO James Foster Issues Letter to ShareholdersFebruary 2, 2023 | finance.yahoo.comEXCLUSIVE: Virax Biolabs Introduces Human Papillomavirus Test Kit In European UnionJanuary 4, 2023 | finance.yahoo.com Get Virax Biolabs Group News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here VRAX Media Mentions By Week VRAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRAX News Sentiment▼0.000.45▲Average Medical News Sentiment VRAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRAX Articles This Week▼00▲VRAX Articles Average Week Get Virax Biolabs Group News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Exicure News Today Cadrenal Therapeutics News Today Chemomab Therapeutics News Today Acurx Pharmaceuticals News Today Tempest Therapeutics News Today GlycoMimetics News Today Pieris Pharmaceuticals News Today Cocrystal Pharma News Today MIRA Pharmaceuticals News Today Enlivex Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRAX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
